Cargando…
Intravitreal bevacizumab
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778565/ https://www.ncbi.nlm.nih.gov/pubmed/29283157 http://dx.doi.org/10.4103/ijo.IJO_802_17 |
| _version_ | 1783294374899089408 |
|---|---|
| author | Khamar, Bakulesh M |
| author_facet | Khamar, Bakulesh M |
| author_sort | Khamar, Bakulesh M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5778565 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57785652018-02-02 Intravitreal bevacizumab Khamar, Bakulesh M Indian J Ophthalmol Letters to the Editor Medknow Publications & Media Pvt Ltd 2018-01 /pmc/articles/PMC5778565/ /pubmed/29283157 http://dx.doi.org/10.4103/ijo.IJO_802_17 Text en Copyright: © 2017 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letters to the Editor Khamar, Bakulesh M Intravitreal bevacizumab |
| title | Intravitreal bevacizumab |
| title_full | Intravitreal bevacizumab |
| title_fullStr | Intravitreal bevacizumab |
| title_full_unstemmed | Intravitreal bevacizumab |
| title_short | Intravitreal bevacizumab |
| title_sort | intravitreal bevacizumab |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778565/ https://www.ncbi.nlm.nih.gov/pubmed/29283157 http://dx.doi.org/10.4103/ijo.IJO_802_17 |
| work_keys_str_mv | AT khamarbakuleshm intravitrealbevacizumab |